Use Of Kutajadi Tablet Along With Glimepiride Metformin In Diabetes Mellitus II

Randomized Controlled Clinical Trial Of Add On Effect Of Kutajadi Tablet Along With Glimepiride-Metformin In Diabetes Mellitus - II - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/102860

Enrollment

Registered

2026-02-03

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having diagnosis of Diabetes Mellitus II and Age of 30 to 70 years with irrespective of gender, education, religion, socioeconomic status 2.Patients presenting sign and symptoms of Pipasa vridhhi (Polydipsia), Prabhut mutrata (Polyuria), Avila mutrata (Turbidity), Nakta mutrata (Nocturia) etc 3.Urine Sugar will be present 4.Blood sugar levels Fasting 126 to 160 mg per dl Postprandial sugar 160 to 250 mg per dl 5.HbA1C 6.5 Percent to 8 percent

Exclusion criteria

Exclusion criteria: 1. Patients having diagnosis Insulin Dependent Diabetes Mellitus (DM I) 2. Patients with Diabetes Mellitus II and on Insulin Therapy 3. Patients having disease conditions like Cardio-vascular disease, Macrovascular and Microvascular complications 4. Patients suffering from Hepatic dysfunction, Renal dysfunction or Liver Cirrhosis 5. Pregnant Women and Lactating mother 6. Patient suffering from Diabetes complications

Design outcomes

Primary

Measure	Time frame
Kutajadi Tablet is effective along with Glemepiride-Metformin in Diabetes Mellitus IITimepoint: 0 Day,30 Day,60 Day,90 Day	—

Secondary

Measure	Time frame
Decrease HbA1C Level and Symptoms after 90 DaysTimepoint: 90 Days	—

Countries

India

Contacts

Public ContactDr Smita Vitthal Lokhande

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center Ashta

yoshitpriya@gmail.com8149556591

Outcome results